Hjem › Lymfom › North Carolina › Durham
Kliniske studier for Lymfom i Durham, NC
17 studier for Lymfom søker deltakere på steder i og rundt Durham (innen ca. 30 miles). Åpne et studie for å se hvem som kan delta og hvordan du kontakter studieteamet.
Offisiell studietekst (engelsk)
Rekrutterer til et studie her? Få det fremtredende øverst på siden – $99 i 30 dager →
CD30 CAR for Relapsed/Refractory CD30+ T Cell Lymphoma
RekruttererFase 2
- Lineberger Comprehensive Cancer Center at University of North Carolina, Chapel Hill · 10 mi unna
A Study of NX-5948 in Adults With CLL/SLL Previously Treated With a Bruton's Tyrosine Kinase Inhibitor and a B-cell Lymphoma-2 Inhibitor (DAYBreak CLL-201)
RekruttererFase 2
- Duke University, Durham
CBL0137 for the Treatment of Relapsed or Refractory Solid Tumors, Including CNS Tumors and Lymphoma
RekruttererFase 1/2
- Duke University Medical Center, Durham
Study of SLS009 (Formerly GFH009) a Potent Highly Selective CDK9 Inhibitor in Patients With Hematologic Malignancies and High-Risk Newly Diagnosed AML
RekruttererFase 1/2
- UNC School of Medicine, Division of Hematology, Chapel Hill · 10 mi unna
DISCOVERY: Evaluating a Decision Support Tool for Adults Seen in Hematology/Oncology Clinics
Rekrutterer
- Lineberger Comphrehensive Cancer Center at University of North Carolina, Chapel Hill · 10 mi unna
Gene Therapy for CD19-Positive Hematologic Malignancies (SENTRY-CD19)
RekruttererFase 1/2
- University of North Carolina at Chapel Hill/ University of North Carolina Medical Center, Chapel Hill · 10 mi unna
A Study to Investigate Ronde-cel Versus Investigator's Choice CD19 CAR T-Cell Therapy
RekruttererFase 3
- Duke Cancer Institute, Durham
DALY II USA/ MB-CART2019.1 for DLBCL
RekruttererFase 2
- Duke University Medical Center - Division of Hematologic Malignancies, Durham
A Study of NX-5948 in Adults With Relapsed/Refractory B-cell Malignancies
RekruttererFase 1
- Duke University Medical Center, Durham
Combating Cancer-Related Fatigue: A Personalized Supportive Care Program
Rekrutterer
- North Carolina Basnight Cancer Hospital, Chapel Hill · 10 mi unna
Registry of Older Patients With Cancer
RekruttererObservasjonsstudie
- Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill, Chapel Hill · 10 mi unna
CA-4948-101: Open-Label, Dose Escalation and Expansion Trial of Emavusertib (CA-4948) in Relapsed or Refractory Primary Central Nervous System Lymphoma (R/R PCNSL)
RekruttererFase 1/2
- Duke University Medical Center, Duke Cancer Center, Durham
A Platform Protocol to Investigate Post-Transplant Cyclophosphamide-Based Graft-Versus-Host Disease Prophylaxis in Patients With Hematologic Malignancies Undergoing Mismatched Unrelated Donor Peripheral Blood Stem Cell Transplantation
RekruttererFase 2
- University of North Carolina, Chapel Hill · 10 mi unna
Symptom Management and Transitioning to Engagement With Post-treatment Care for Adolescent and Young Adult Cancer Survivors
Rekrutterer
- Duke Cancer Institute, Durham
Study of Kappa Chimeric Antigen Receptor (CAR) T Lymphocytes Co-Expressing the Kappa and CD28 CARs for Relapsed/Refractory Kappa+ Non-Hodgkin Lymphoma and Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma.
RekruttererFase 1
- Lineberger Comprehensive Cancer Center at University of North Carolina, Chapel Hill · 10 mi unna
Tissue, Blood, and Body Fluid Sample Collection From Patients With Hematologic Cancer
RekruttererObservasjonsstudie
- Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill, Chapel Hill · 10 mi unna
A Randomized Phase II Study Of Bruton Tyrosine Kinase Inhibitor With Or Without Venetoclax In Veterans With Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL)
RekruttererFase 2
- Durham VA Medical Center, Durham, NC, Durham
Lymfom-studier i andre byer
- Houston, TX34 studier
- Boston, MA33 studier
- New York City, NY33 studier
- Washington, DC23 studier
- Baldwin Park, CA21 studier
- Chicago, IL20 studier
- St. Louis, MO15 studier
- Philadelphia, PA15 studier
- Cleveland, OH14 studier
- Edison, NJ12 studier
- Atlanta, GA12 studier
- Seattle, WA12 studier
Andre studier i Durham
- Brystkreft63 studier
- Kreft (alle typer)58 studier
- Ikke-småcellet lungekreft39 studier
- Multipelt myelom37 studier
- Metastatisk kreft33 studier
- Akut myelogen leukemi33 studier
- Lungekreft32 studier
- Prostatakreft32 studier
- Kolorektal kreft28 studier
- Kronisk lymfatisk leukemi27 studier
- Eggstokkreft27 studier
- Hjertesvikt26 studier
Fra ClinicalTrials.gov, data hentet 5. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.